Mai PeptideTirzepatide
Ordered Tirzepatide from Mai Peptide? Mail in a sample (US only) and let us test it.
Test my supplyMai Peptide tirzepatide is weighed down by repeated purity misses and two recent identity failures, not just older noise. Key details are July/August identity fails, September's 91.1% purity, and a later pass that only partly steadies it.
Corporate and domain records point past the storefront to a Xi'an/Shaanxi sales trail, HK-numbered contacts and unresolved UBO. The report maps Carrd COAs, crypto/off-platform payment rails, lookalike domains and parasite-review promotion.
Unlock original COAs
View and download original lab PDFs for Finnrick tests, including Mai Peptide rows.
Cancel anytime
Ordered Tirzepatide from Mai Peptide? Mail in a sample (US only) and let us test it.
Test my supplyAbout Mai Peptide test results from Finnrick
Mai Peptide is a peptide vendor tracked in Finnrick's independent testing dataset. This page compiles batch-level results across 11 peptides and 125 tests, including ratings, observed price signals, recent test dates, and correction history where available.
Finnrick ratings are calculated from published sample data using the selected rating standard. The default standard evaluates purity, dose accuracy, and label quality, then adjusts low-volume results so small sample counts do not appear more certain than the data supports.
The most visible Mai Peptide peptides in this dataset are Semaglutide (3 tests). Use the peptide table above to compare the current Finnrick rating, price per mg, and sample volume for each peptide.
Recent tests and corrections are shown below when available. Samples may be acquired by Finnrick directly or submitted through Finnrick testing programs; the goal is to make safety and supply-chain evidence easier to evaluate than vendor marketing claims alone. This page currently lists 125 recent tests.
Ordered Tirzepatide from Mai Peptide? Mail in a sample (US only) and let us test it.
Test my supply